Chimerix Inc 's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Chimerix Inc 's ROA in the fourth quarter of 2024?
Chimerix Inc recorded a cumulative net loss of $-88 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on assets (ROA) of -52.36%.

However, within the Healthcare sector 693 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from 4184 to 4840.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Total Assets Change	-30.91 %	-29.66 %	-26.18 %	-25.08 %	-24.25 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-88	-84	-85	-83	-82
Return On Assets (TTM)	-52.36 %	-45.15 %	-41.97 %	-37.96 %	-35.12 %
CMRX's Total Ranking	# 4840	# 4184	# 4171	# 4151	# 4713
Total Assets (TTM) in million	146	158	178	193	211
Seq. Total Assets Change	-7.7 %	-11 %	-8.05 %	-8.54 %	-6.02 %
Seq. Net Income Change	-	-	-	-	-

CMRX's 5 Years Annual ROA >> Back to CMRX Management Effectiveness >> Compare CMRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 310
Sector	# 694
Overall	# 4768

Return On Assets Statistics
High	Average	Low
119.67 %	-37 %	-128.49 %
(Sep 30 2022)		(Dec 31 2021)

Financial Statements
Chimerix Inc 's Assets	$ 146 million	CMRX's Balance sheet
Chimerix Inc 's Income	$ -23 million	Quarterly CMRX's Income Statement
CMRX's Income by Division		See CMRX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-30.91 %	-24.25 %	181.58 %	19.56 %	-30.58 %
Total Assets in million	146	211	279	99	83
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-88	-82	172	-173	-44
Annual Return On Assets	-60.54 %	-38.85 %	61.71 %	-174.84 %	-52.52 %

CMRX's 5 Years Annual ROA >> Back to CMRX Management Effectiveness >> Compare CMRX ROA to its Competitors

More Return On Assets Ratios
CMRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CMRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CMRX's Competitors
Subscribers only: Roa for Chimerix Inc 's Suppliers
Subscribers only: Return On Assets for CMRX's Customers

You may also want to know
CMRX's Roi	CMRX's Inventory Turnover Ratio	CMRX's Growth Rates	CMRX's Dividend Comparisons
	CMRX's Profitability Ratios	CMRX's Asset Turnover Ratio	CMRX's Dividend Growth
CMRX's Roe	CMRX's Valuation Ratios	CMRX's Financial Strength Ratios	CMRX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.